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Abstract
Iron-sulphur cluster biogenesis requires coordinated delivery of iron and sulphur to scaffold
proteins, followed by transfer of the assembled clusters from scaffold proteins to target proteins.
This complex process is accomplished by a group of dedicated iron-sulphur cluster assembly
proteins that are conserved from bacteria to humans. While sulphur in iron-sulphur clusters is
provided by L-cysteine via cysteine desulfurase, the iron donor(s) for iron-sulphur cluster
assembly remains largely elusive. Here we report that among the primary iron-sulphur cluster
assembly proteins, IscA has a unique and strong binding activity for mononuclear iron in vitro and
in vivo. Furthermore, the ferric iron centre tightly bound in IscA can be readily extruded by L-
cysteine, followed by reduction to ferrous iron for iron-sulphur cluster biogenesis. Substitution of
the highly conserved residue tyrosine 40 with phenylalanine (Y40F) in IscA results in a mutant
protein that has a diminished iron binding affinity but retains the iron-sulphur cluster binding
activity. Genetic complementation studies show that the IscA Y40F mutant is inactive in vivo,
suggesting that the iron binding activity is essential for the function of IscA in iron-sulphur cluster
biogenesis.
Introduction
Throughout evolution, iron-sulphur clusters have become integral parts of diverse
physiological processes including photosynthesis, nitrogen fixation, sugar metabolism, co-
factor biogenesis, RNA modification and translation, DNA replication and repair, and gene
expression regulation.1-4 While iron-sulphur clusters can be assembled in proteins in vitro
with ferrous iron and sulphide, iron-sulphur cluster assembly in vivo requires a group of
dedicated proteins that are conserved from bacteria to humans.5 In Escherichia coli, the
proteins encoded by a gene cluster iscSUA-hscBA-fdx are primarily responsible for iron-
sulphur cluster assembly under normal growth conditions.5 The homologues of the six
proteins encoded by iscSUA-hscBA-fdx have been identified in eukaryotic organisms.2
Among them, IscS is a cysteine desulfurase that catalyzes desulfurization of L-cysteine6-8
and provides sulphur for iron-sulphur cluster assembly in a scaffold protein IscU.9-11 IscU in
turn transfers the assembled clusters to target proteins.12, 13 IscA has been characterized as
an alternative scaffold or intermediate carrier for iron-sulphur cluster assembly.14, 15 A
comprehensive characterization of iron-sulphur cluster binding in an IscA homolog NifIscA
from Azotobacter vinelandii has recently been reported.16 Two heat shock cognate proteins,
HscB and HscA, have specific interactions with IscU17 and promote the transfer of
assembled clusters from IscU to target proteins in an ATP-dependent reaction.18, 19
Ferredoxin, which contains a stable [2Fe-2S] cluster,20 is likely involved in the reductive
formation of a [4Fe-4S] cluster in scaffold protein IscU 21, 22.
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While the sulphur donor for iron-sulphur cluster assembly has been well established,6-8 the
iron donor(s) remains largely elusive. Frataxin, a mitochondrial protein that is linked to
neurodegenerative disease Friedreich’s ataxia,23 has previously been characterized as a
likely iron donor for iron-sulphur cluster assembly.24, 25 Deficiency of frataxin results in
diminished activity of iron-sulphur enzymes in yeast cells,26 and frataxin has physical
interactions with iron-sulphur cluster assembly protein IscU,27-29 the IscU/IscS
complex,30, 31 and with the iron-sulphur enzyme aconitase in mitochondria.32 However,
frataxin has a weak iron binding activity with an iron binding constant of 4 to 55
μM.24, 33, 34 Such a low iron binding affinity may preclude frataxin from binding any
significant amounts of iron in mitochondria under normal physiological conditions.
Furthermore, deletion of frataxin homologue CyaY in E. coli does not affect iron-sulphur
cluster biogenesis,35 and frataxin-deficient yeast cells can be rescued by either expressing
ferritin36 or vacuolar iron transporter CCC1.37 In fact, scavenging H2O2 can effectively
restore iron-sulphur enzyme activities in a Drosophila model of Friedreich’s ataxia.38 Thus,
the primary function of frataxin could be to maintain iron homeostasis under oxidative
stress39, 40 or to modulate overall iron-sulphur cluster assembly in cells.30, 31
In previous studies, we reported that unlike other iron-sulfur cluster assembly scaffold
proteins such as IscU, IscA has a strong iron binding activity with an apparent iron
association constant of 1.0 × 1019 M−1.41-45 A similar strong iron binding activity has been
observed for IscA homologues from humans,46 yeast cells,47 and A. vinelandii NifIscA.48 In
this study, we present new evidence showing that among the primary iron-sulphur cluster
assembly proteins, IscA is unique in binding iron, and that the tightly bound ferric iron in
IscA can be readily extruded by L-cysteine, followed by reduction to ferrous iron for iron-
sulphur cluster assembly. Site-directed mutagenesis studies show that the iron-binding
activity is crucial for the physiological function of IscA in iron-sulphur cluster biogenesis.
Experimental
Protein preparation
The iron-sulphur cluster assembly proteins IscS, IscU, IscA, HscB, and HscA from E. coli
were prepared as described previously.43 The IscA mutant in which tyrosine 40 was
substituted with phenylalanine (Y40F) was constructed using the site-directed mutagenesis
kit (Stratagene co). The mutation of gene iscA in the cloned plasmid was confirmed by
direct sequencing. Human frataxin was subcloned from plasmid pETHF249 to expression
plasmid pET28b+ and prepared as described in.46 The E. coli frataxin homologue CyaY was
prepared as described in.44 The protein concentration was determined from the absorption
peak at 260 nm or 280 nm using the previously published extinction coefficient for each
protein.
In vitro iron binding and iron-sulphur cluster assembly in IscA
For the iron binding experiments, each of purified iron-sulphur cluster assembly proteins (50
μM in monomer) was incubated with Fe(NH4)2(SO4)2 (50 μM) and sodium citrate (5 mM)
in buffer containing NaCl (200 mM), Tris (20 mM, pH 8.0) in the presence of dithiothreitol
(2 mM) at room temperature for 20 min, followed by passing through a High-trap Desalting
column. Total iron contents in re-purified protein samples were determined using an iron
indicator FerroZine as described in.50 For iron-sulphur cluster assembly, purified IscA was
incubated with IscS (0.5 μM), Tris (20 mM, pH 8.0), NaCl (200 mM), Fe(NH4)2(SO4)2 (50
μM), and dithiothreitol (2 mM) at 37°C for 5 min under anaerobic conditions. L-cysteine (1
mM) was then added to initiate the iron-sulphur cluster assembly reaction. The amount of
iron-sulphur clusters assembled in protein was monitored in a Beckman DU-640 UV-Visible
spectrophotometer.
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EPR (electron paramagnetic resonance) spectra were recorded at X-band on a Bruker
ESP-300 EPR spectrometer using an Oxford Instruments ESR-9 flow cryostat. The routine
EPR conditions were: microwave frequency, 9.45 GHz; microwave power, 10 mW;
modulation frequency, 100 kHz; modulation amplitude, 2.0 mT; temperature, 10 K; receive
gain, 1.0×105.
In vivo activity assay of the IscA Y40F mutant
For the in vivo activity of the IscA Y40F mutant, gene encoding Y40F was cloned into a
plasmid pBAD (Invitrogen co.). The constructed plasmid pBAD/Y40F was introduced into
an E. coli mutant in which gene iscA and its paralogue sufA were in-frame deleted.51 The E.
coli iscA/sufA double mutant was viable in rich LB medium, but had a null-growth
phenotype in M9 minimal medium under aerobic conditions.51 The E. coli iscA/sufA double
mutant cells containing pBAD/iscA and pBAD served as positive and negative control,
respectively.
Results and discussion
IscA has a unique iron binding activity among the iron-sulphur cluster assembly proteins
To explore the iron binding activity of the primary iron-sulphur cluster assembly proteins
encoded by the gene cluster iscSUA-hscBA-fdx from E. coli,5 we expressed each protein in
wild-type E. coli cells grown in LB media. Each protein was purified to a single band on the
SDS-PAGE gel.
Because ferredoxin contained a stable [2Fe-2S] cluster,20 ferredoxin was not included for
the iron binding analysis. Among the other iron-sulphur cluster assembly proteins encoded
by iscSUA-hscBA-fdx, only purified IscA contains 0.09±0.02 iron atoms per IscA dimer
(Fig. 1a). No acid-labile sulphur is detectable in purified IscA, indicating that purified IscA
does not contain any significant amounts of iron-sulphur clusters.
The iron binding activity of purified iron-sulphur cluster assembly proteins is also analyzed
in vitro. Each purified protein is incubated with freshly prepared ferrous iron in the presence
of dithiothreitol under aerobic conditions, followed by re-purification of protein Fig. 1b)
shows that while the iron content in IscA is increased to 1.05±0.10 iron atoms per IscA
dimer after incubation with an equivalent amount of ferrous iron (relative to protein
monomer), the iron content in other proteins is less than 0.1 iron atoms per protein dimer,
demonstrating that IscA has a unique iron binding activity.
The only other candidate proposed for the iron donor to iron-sulphur cluster assembly in
scaffold protein IscU is frataxin and its bacterial homologue CyaY.24, 25 To explore the iron
binding activity of frataxin/CyaY in vitro under the same experimental conditions, purified
E. coli CyaY and human frataxin are incubated with an equivalent amount of ferrous iron in
the presence of dithiothreitol. Very little or no iron binding is found in re-purified CyaY and
human frataxin (data not shown), suggesting that unlike IscA from E. coli 41 and humans,46
CyaY/frataxin has a very weak iron binding activity in the presence of dithiothreitol.
The ferric iron centre in IscA can be extruded b y L-cysteine, followed by reduction to
ferrous iron
To access the iron in IscA for iron-sulphur cluster biogenesis, the iron stored in the protein
must be quickly released when there is such a demand. Previously, we reported that L-
cysteine, but not other related biological thiols including N-acetyl-L-cysteine or reduced
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glutathione, can efficiently release iron from the iron-bound IscA.52 However, the
mechanism underlying the L-cysteine-mediated iron release from IscA was not clear.
The iron-bound IscA has an unusual EPR signal at g = 4.3 and 6.0.41 The signal is
completely eliminated upon removal of iron from the protein, and fully restored after
reconstitution with iron, indicating that the EPR signal represents the iron binding in IscA.41
Interestingly, similar EPR signal was previously reported for the S = 3/2, reduced [4Fe-4S]
cluster in proteins such as nitrogenase53 and 2-hydroxyglutaryl-CoA dehydratase.54 While
further biophysical studies will be important to determine the spin state of the iron center in
E. coli IscA, recent optical and magnetic spectroscopic characterization of NifIscA, an IscA
homologue from A. vinelandii, provided comprehensive and convincing evidence for the
assignment of the iron site in NifIscA to a ferric iron in an unusual rhombic spin S = 3/2
state.48 The EPR spectra of the iron-bound NifIscA from A. vinelandii48 and the iron-bound
IscA from E. coli41 are essentially the same. Furthermore, the iron center in both E. coli
IscA and NifIscA is redox active: the EPR signal at g = 4.3 and 6.0 disappears when the iron
centre in IscA is reduced by sodium dithionite.41, 48
To follow the process of the L-cysteine-mediated iron release from IscA, we used EPR to
monitor the redox state of the iron centre in IscA when the iron-bound IscA was incubated
with L-cysteine under aerobic conditions. At different time points, aliquots were taken from
the incubation solution after addition of L-cysteine for EPR measurements.
Fig. 2 shows that upon addition of L-cysteine, the EPR signal at g = 4.3 and 6.0 of the iron-
bound IscA is quickly replaced with a new EPR signal at g = 4.3, representing “free” ferric
iron in solution.55 After further incubation (over 20 min), the newly formed EPR signal at g
= 4.3 is gradually decreased, indicating that the “free” ferric iron is reduced to the EPR-
silent ferrous iron. As a control, incubation of the iron-bound IscA with N-acetyl-L-cysteine
or reduced glutathione does not affect the EPR signal at g = 4.3 and 6.0 of the iron-bound
IscA (data not shown). On the other hand, D-cysteine has the same activity as L-cysteine in
releasing iron from IscA,52 suggesting that the redox property, but not stereochemistry, of L-
cysteine is responsible for the iron release from IscA.
The transition of the EPR signal of the iron-bound IscA from g = 4.3 and 6.0 to g = 4.3 upon
addition of L-cysteine indicates that the L-cysteine-mediated iron release from IscA may
have two distinctive steps. In the first step, L-cysteine extrudes ferric iron from IscA via
ligand exchange to form the L-Cys-Fe3+-IscA and/or the L-cys-Fe3+ complex which
attributes to the observed EPR signal at g = 4.3 (Fig. 2). In the second step, the L-Cys-Fe3+-
IscA and/or L-cys-Fe3+ complex is reduced by L-cysteine to the EPR-silent ferrous iron
which will be accessible for iron-sulphur cluster biogenesis.43
Mutation at residue tyrosine 40 to phenylalanine diminishes the iron binding activity of
IscA
In crystal structure, E. coli IscA is a homodimer with the three conserved cysteine residues
(Cys-35, Cys-99 and Cys-101) projected to form a “cysteine pocket” between two
monomers.56, 57 Mutation of any of the three conserved cysteine residues to serine produced
IscA mutant proteins that have a diminished iron binding activity 58 and are inactive in E.
coli cells.51 However, because the cysteine residues may accommodate either a
mononuclear iron or iron-sulphur cluster in IscA, mutation of cysteine residues would have
affected both the iron and iron-sulphur cluster binding in the protein.
Among the amino acid residues that are in the vicinity of the putative iron binding site in
IscA dimer, tyrosine 40 is highly conserved and located in the interface between two IscA
monomers (Fig. 3). Unlike other nearby conserved residues that form a hydrophobic packing
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between IscA monomers,56 the hydroxyl group of tyrosine 40 may act as a possible
oxygenic ligand for iron binding in IscA dimer.48
To explore the role of tyrosine 40 in the iron binding and iron-sulphur cluster binding of
IscA, we constructed an IscA mutant in which tyrosine 40 was substituted with
phenylalanine (Y40F). The IscA mutant Y40F protein was purified (Supplementary Figure
A), and incubated with increasing concentrations of ferrous iron, followed by re-purification
of the protein. Fig. 4 shows that unlike wild-type IscA, the absorption peak at 315 nm of the
iron binding in Y40F is only slightly increased after incubation with ferrous iron in the
presence of dithiothreitol. The iron content analyses revealed that after incubation with two-
fold excess of iron per protein dimer, the ratio of iron to the wild-type IscA dimer is
1.05±0.10, while the ratio of iron to the IscA mutant Y40F dimer is less than 0.15
(Supplementary Figure B). The wild-type IscA and Y40F mutant proteins after
reconstitution with two fold excess of iron were re-purified concentrated, and subjected to
the EPR measurements. While wild-type IscA has a typical EPR spectrum of the iron-bound
protein with g = 4.3 and 6.0, Y40F only has a small EPR signal at g = 4.3 region (data not
shown). In the light of recent publication on the iron binding property of NifIscA,48 it would
be interesting to determine whether tyrosine 40 actually provides the oxygenic ligand for the
iron binding in IscA. Regardless, the results shown in Figure 4 and Supplementary Figure
clearly demonstrate that mutation at Y40F severely diminishes the iron binding activity of E.
coli IscA in vitro.
Next, we explored the iron-sulphur cluster binding activity of the wild-type IscA and IscA
mutant Y40F. Purified IscA and the IscA mutant Y40F proteins were incubated with ferrous
iron, L-cysteine, and a catalytic amount of IscS in the presence of dithiothreitol under
anaerobic conditions. After 20 min incubation, the iron-sulphur cluster assembly in IscA
was analyzed. Fig. 5 shows that like wild-type IscA, the IscA mutant Y40F retains the iron-
sulphur cluster binding activity, suggesting that mutation of Y40F does not significantly
affect the iron-sulphur cluster assembly in IscA in vitro.
IscA mutant Y40F is inactive in E. coli cells
E. coli has at least two IscA paralogs: ErpA and SufA. ErpA, which maps at a distance from
any iron-sulphur cluster assembly-related genes, has been characterized as a dedicated
scaffold for maturation of the key iron-sulphur enzymes in the isoprenoids biosynthesis
pathway.59 SufA, on the other hand, is a member of second iron-sulphur cluster assembly
gene cluster sufABCDSE in E. coli.60 Purified SufA, like IscA, has a strong iron binding
activity and provides iron for iron-sulphur cluster assembly in IscU in vitro.51 While
deletion of IscA or SufA in E. coli cells only has a mild effect on cell growth, deletion of
both IscA and SufA results in a null-growth phenotype in M9 minimal media under aerobic
conditions.51, 61 Re-introducing IscA or SufA restores the cell growth of the E. coli iscA/
sufA double mutant,51, 62 suggesting that IscA and SufA are complementary to each other.
To determine the in vivo activity of the IscA mutant Y40F, a plasmid expressing Y40F was
introduced into the E. coli iscA/sufA double mutant cells. The cells were inoculated in M9
minimal media and grown under aerobic conditions. Fig. 6 shows that unlike wild-type
IscA, Y40F failed to restore the cell growth of the E. coli iscA/sufA double mutant in M9
minimal media under aerobic conditions. Since the IscA mutant Y40F has a diminished iron
binding activity but retains the iron-sulphur cluster binding activity, we propose that the iron
binding activity is essential for the physiological function of IscA in iron-sulphur cluster
biogenesis.
Phylogenomic analyses revealed that IscA is highly conserved from prokaryotic to
eukaryotic organisms.63 In A. vinelandii, depletion of IscA produces a null-growth
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phenotype in modified Burks minimal medium under elevated oxygen conditions.64 In E.
coli, deletion of IscA and its paralog SufA results in a mutant that fails to grow in M9
minimal media under aerobic conditions.51, 61 In S. cerevisiae, depletion of IscA
homologues leads to iron accumulation in mitochondria and dependency on lysine and
glutamate in media.65 In human Hela cells, RNAi knockdown of IscA homologue results in
decreased activities of iron-sulphur enzymes in both mitochondria and cytosol.66 Evidently,
IscA has a crucial role for iron-sulphur cluster biogenesis, especially under aerobic
conditions. However, the physiological function of IscA remains controversial. One
hypothesis stated that IscA acts as an alternative scaffold protein or intermediate carrier for
iron-sulphur cluster biogenesis, as IscA is able to bind an iron-sulphur cluster and transfer
the cluster to target proteins.14-16 However, unlike other scaffold proteins such as IscU,9
IscA has a strong iron binding activity with a maximum binding of one iron per IscA
dimer.41-45 Recent spectroscopic characterization of NifIscA from A. vinelandii confirms
that NifIscA is able to bind one iron per dimer, and that the the iron center in IscA is in an
unusual intermediate S = 3/2 spin state.48 The results presented in this study provide new
evidence for the hypothesis that IscA is a bona fide iron binding protein. Among the primary
iron-sulphur cluster assembly proteins encoded by the gene cluster iscSUA-hscBA-fdx5 and
the putative iron donor frataxin/CyaY,24, 25 only IscA has a strong binding activity for
mononuclear iron in the presence of dithiothreitol. Furthermore, the ferric iron centre tightly
bound in IscA can be readily extruded by L-cysteine, followed by reduction to ferrous iron.
Additional studies further reveal that mutation at tyrosine 40, a possible oxygenic ligand for
the iron binding in IscA,48 diminishes iron binding activity but retains iron-sulphur cluster
binding activity of IscA. Genetic complementation studies show that Y40F is inactive in
vivo, suggesting that the iron binding activity is essential for the physiological function of
IscA. Collectively, the results support the hypothesis that IscA may act as an iron donor for
iron-sulphur cluster biogenesis. Nevertheless, since IscA can also bind iron-sulphur
clusters 14, 15 and transfer the assembled clusters to target proteins,16 the role of IscA as an
alternative scaffold protein cannot be excluded. Perhaps, the iron binding in IscA could be
the initial step for iron-sulphur cluster assembly either in IscA or in other scaffold proteins
such as IscU.43 Evidently, additional experiments are required to illustrate the role of IscA
in iron-sulphur cluster biogenesis.
It is worth pointing out that IscA/SufA is dispensable for cell growth of E. coli in M9
minimal media under anaerobic conditions.45 Interestingly, most anaerobic organisms
contain no IscA homologues and almost all aerobic organisms contain at least one copy of
IscA in their genomes.63 It may be envisioned that under anaerobic conditions intracellular
“free” iron is more freely available for iron-sulphur cluster biogenesis, and IscA is
unnecessary. In aerobic organisms, a functional IscA will be required to recruit intracellular
iron and deliver iron or iron-sulphur clusters for iron-sulphur cluster biogenesis under
aerobic conditions.
Conclusions
Among the iron-sulphur cluster assembly proteins, IscA is unique in binding mononuclear
iron. The tightly-bound iron centre in IscA can be readily extruded by L-cysteine, followed
by reduction to ferrous iron. An IscA mutant that has a diminished iron binding activity but
retains iron-sulphur cluster binding in vitro is inactive in vivo. The results suggest that IscA
is a bona fide iron binding protein and that the iron binding activity is essential for
physiological function of IscA in iron-sulphur cluster biogenesis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Iron binding of primary iron-sulphur cluster assembly proteins. Iron-sulphur cluster
assembly proteins IscS, IscU, IscA, HscB and HscA were purified from E. coli cells grown
in LB media. a), iron content of purified iron-sulphur cluster assembly proteins. Iron content
was presented as the ratio of iron atoms per protein dimer. b), iron content of iron-sulphur
cluster assembly proteins (50 μM in monomer) after incubation with Fe(NH4)2(SO4)2 (50
μM), sodium citrate (5 mM) and dithiothreitol (2 mM). Proteins were re-purified from
incubation solutions. Iron content was presented as the ratio of iron atoms per protein dimer.
The data are averages plus standard deviations from three independent experiments.
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L-cysteine-mediated iron release from IscA. Iron-bound IscA dimer (300 μM) was
incubated with 2 mM L-cysteine under aerobic conditions. Aliquots were taken at indicated
time and frozen immediately for the liquid helium-temperature EPR measurements.
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Location of Tyr-40 in E. coli IscA dimer. Tyr-40 is located in the interface between two
IscA monomers, and is in the vicinity of the putative iron binding site (adapted from 56). The
conserved iron binding residues (Cys-99 and Cys-101) of IscA are not visible in the electron
density map, likely because of the high flexibility.
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IscA mutant Y40F has a diminished iron binding activity. a), purified wild-type IscA dimer
(25 μM) was incubated with indicated concentrations of Fe(NH4)2(SO4)2 in the presence of
dithiothreitol (2 mM) at room temperature for 20 min, followed by re-purification of protein.
Spectra were calibrated to the same amplitude of the absorption peak at 260 nm of the IscA
sample after reconstitution with two-fold excess of iron. b), same as in a), except IscA
mutant Y40F dimer (25 μM) was used. Spectra were calibrated to the same amplitude of the
absorption peak at 260 nm of the Y40F sample after reconstitution with two-fold excess of
iron.
Landry et al. Page 13














In vitro iron-sulphur cluster assembly in IscA and IscA mutant Y40F. Purified IscA mutant
Y40F (spectrum 1) or wild-type IscA dimer (spectrum 2) (25 μM) was incubated with IscS
(0.5 μM), Fe(NH4)2(SO4)2 (100 μM), dithiothreitol (2 mM) in buffer containing Tris (20
mM, pH 8.0) and NaCl (200 mM) at 37°C under anaerobic conditions. L-cysteine (1 mM)
was then added to the incubation solutions to initiate the iron-sulphur cluster assembly
reaction. Spectra were taken 20 min after addition of L-cysteine. The absorption peak at 415
nm reflects the iron-sulphur cluster formation in IscA.
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Complementary activity of the IscA mutant Y40F in E. coli mutant with deletion of IscA
and its paralog SufA. The E. coli wild-type (MC4100) and the mutant cells with deletion of
IscA/SufA (iscA−/sufA−) containing expression plasmids were grown in M9 minimal media
at 37°C under aerobic conditions. Cell growth was monitored at O.D. at 600 nm for 14 hours
after inoculation of 1:100 dilutions.
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